Guidelines
The German Society for Neurogastroenterology and Motility (DGNM) develops guidelines and recommendations in close cooperation with the working groups of other professional societies. In addition, it organises hands-on courses on functional diagnostics in the gastrointestinal tract. Here we provide information about publications on the indication and performance of functional diagnostic examinations and therapies in gastroenterology.
As our guidelines are intended for German physicians and clinicians, they will only be provided in German. Please find English guidelines on the homepage of the European Society of Neurogastroenterology & Motility (ESNM).
S2k-Guideline GERD (2023)
Guideline of the DGVS
Gastro-oesophageal reflux disease (GERD) is one of the most common diseases of the gastrointestinal tract and is considered a widespread disease (1). In addition to the high prevalence and the significant reduction in quality of life, the significance of the disease lies in the broad clinical spectrum of symptoms, complications and secondary diseases. The numerous new findings in the diagnosis and therapy of GERD, with some paradigm shifts, were the motivation for updating the GERD guideline
S2k Guideline Chronic constipation (2022)
Definition, pathophysiology, diagnosis and therapy.
Joint guideline of the DGVS and DGNM.
The aim of this interdisciplinary S2k guideline was to summarise the current state of knowledge on the definition, pathophysiology, diagnosis and therapy of chronic constipation in adults on the basis of scientific evidence, to evaluate it in expert consensus and to derive practice-relevant recommendations from it.
Update S3-Leitlinie Reizdarmsyndrom (2021)
Gemeinsame Leitlinie der DGVS und DGNM.
Das Reizdarmsyndrom zählt zu den häufigsten Erkrankungen des Verdauungssystems. Zum typischen Beschwerdebild gehören Bauchschmerzen, Krämpfe, Blähungen und Stuhlgangsveränderungen wie z. B. Diarrhö und/oder Obstipation. Die erste deutsche S3-Leitlinie zum Reizdarmsyndrom stammt aus dem Jahr 2011. Im Juli 2021 wurde, basierend auf neuesten Erkenntnissen, eine aktualisierte Version der Leitlinie publiziert. Neben einem Überblick über die Bereiche Epidemiologie, Pathophysiologie, Diagnostik und Therapie des Reizdarmsyndroms aus der aktuellen Leitlinie soll im Folgenden auch die Therapie von Schmerzen und Blähungen als Symptomen des Reizdarms dargestellt werden.
Update S3-Leitlinie Intestinale Motilitätsstörungen (2021)
Gemeinsame Leitlinie der DGVS und DGNM
Die vorliegende Leitlinie richtet sich an die an Diagnostik und Therapie beteiligten Berufsgruppen (Allgemeinmediziner, Internisten, Pathologen, Chirurgen etc.) ebenso wie an betroffene Patienten und an Leistungserbringer (Krankenkassen, Rentenversicherungsträger). Sie soll der evidenzbasierten Fort- und Weiterbildung dienen und auf dieser Basis eine Verbesserung der medizinischen Versorgung der Patienten in der ambulanten und stationären Versorgung erreichen.
Aktualisierte S2k-Leitlinie Zöliakie (2021)
DGVS und weitere Arbeitsgruppen
Das Ziel der interdisziplinären S2k-Leitlinie „Zöliakie, Weizenallergie und Weizensensitivität“ ist es, den aktuellen Kenntnisstand zu klinischem Bild, Diagnostik, Therapie, Pathologie und refraktärer Zöliakie einschließlich der mit Zöliakie assoziierten Malignome bei Kindern, Jugendlichen und Erwachsenen auf Basis der wissenschaftlichen Evidenz zusammenzufassen, im Expertenkonsens zu bewerten und daraus praxisrelevante Empfehlungen abzuleiten.
High-resolution oesophageal manometry (2018)
Recommendations of the German Society for Neurogastroenterology and Motility (DGNM) and the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS).
Oesophageal manometry allows accurate assessment of oesophageal contractility and is therefore the reference method for diagnosing oesophageal motility disorders. The significance of the method has been further enhanced by the introduction of high-resolution oesophageal manometry (HRM), which displays the functional anatomy of the oesophagus in a visually intuitive way.
Statement on the benefit assessment of linaclotide (2013)
Statement on the benefit assessment of linaclotide.
Template for the submission of a written statement on the benefit assessment according to § 35a SGB V. The statement, including the full text of the literature and further appendices, is to be submitted to the G-BA electronically. The completed document is to be submitted to the G-BA in Word format.
Anorectal manometry in adults (2007)
Joint recommendation of the DGNM, DGVS, DGAV and DGK.
Updated and further developed recommendations of the German Society for Neurogastroenterology and Motility, evaluated and co-edited by the Proctology Working Group of the German Society for Digestive and Metabolic Diseases (DGVS), the Coloproctology Working Group of the German Society for Visceral Surgery(DGAV) and the German Society for Coloproctology (DGK).
24-hour oesophageal pH-metry (2003)
Joint recommendation of the DGNM and the ÖGGH.
Recommendations for indications, performance and interpretation of 24-hour oesophageal pH-metry in adults. Prepared by the German Society for Neurogastroenterology and Motility and the Working Group for Gastrointestinal Dysfunction and Functional Diagnostics of the Austrian Society forGastroenterology and Hepatology.
Oesophageal Scintigraphy (2002)
Recommendation of the working group Neurogastroenterology and Motility.
Recommendations on indications for oesophageal function scintigraphy, the performance of this examination and the evaluation of the data obtained by an expert group of the Neurogastroenterology and Motility Working Group.
Manometry of oesophagus and anorectum (1999)
Recommendations of the Working Group Gastrointestinal Motility and Function.
Recommendations for the indication and performance of functional diagnostic examinations in gastroenterology.